In an individual patient-level meta-analysis of 7161 people with asthma, each 0·5-point rise in ACQ-5 symptom score was only modestly linked to future severe attacks (aRR 1·09) and did not predict mepolizumab response; blood eosinophils and FeNO did.
Meta-analysisn = 7,161
Couillard et al. Symptom burden to characterise, predict, and prevent asthma attacks: a patient-level meta-analysis of randomised trials and translational prospective studies